Akebia Therapeutics

AKBANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$252.139 M

$0.91 -4.66%

Close of 7 Aug 2026

Revenue

$236.2M

#2245 by revenue

Earnings

-$5.30M

Loss-making

Shares outstanding

277,106,245

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#251MacrogenicsMGNX$256.8M
#252Whitehawk TherapeuticsWHWK$256.0M
#253Akebia TherapeuticsAKBA$252.1M
#254Emergent BioSolutionsEBS$249.7M
#255Sol-Gel TechnologiesSLGL$247.3M

Where these numbers come from

Share counts and financials for Akebia Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.